Marly-Ann Spronken : “ Our goal is ‘More for less’: more value, better outcomes, greater convenience, access and simplicity; all for less cost, complexity, and time required by the patient and the provider, in a way that expands what is currently possible.”Any combination of activities or technologies that break existing performance tradeoffs in the attainment of an outcome.Working to improve care and health outcomes, all while reducing costs and spending. What innovations are most likely to help stakeholders achieve these goals and transform health care over the next years?
Innovations in health care can enable breakthrough performance is a report of Deloitte. The Deloitte Center for Health Solutions surveyed leaders to identify the innovations they think are most likely to transform health care.
The health care industry is breaking current constraints and expands the frontier to achieve true breakthrough performance. While the constraints are many, the traditional, dominant, fee-for-service (FFS) payment model, in particular, does not align provider incentives with the goal of achieving more for less.
Incorporating the top 10 innovations into business models will require changing how health care organizations currently prevent, diagnose, monitor, treat disease and enhance quality of life. Leaders should determine which innovations break performance trade-offs, or create more for less, in a way that impacts their core business. They should consider building ecosystems that embrace non-traditional players and sources of knowledge outside their own four walls. They should also consider building pilots before investing in scale, learn to embrace change, and evaluate new revenue sources. And, organizations should strive to be agile in anticipating and adjusting their strategies as innovations continue to evolve.
“More value, better outcomes, greater convenience, access and simplicity; all for less cost, complexity, and time required by the patient and the provider.” Read the full report of Deloitte.
Contact the Deloitte Health Care specialist: bcopeland@deloitte.com
INNOVATION in BREAST AUGMENTATION SURGERY
There is still a great deal of misunderstanding about modern breast implants, in spite of the extensive information available on the web and from plastic surgeons themselves.
New generation silicone Implants are safe. While there has been debate over the risk of complications with older silicone implant models from before the turn of the new millennium, modern silicone gel implants have an excellent safety record. Any woman who is now considering breast augmentation needs to understand that the latest generations of silicone gel implants have a solid track record of safety and are likely some of the most studied medical devices in the history of medicine.
The FDA has approved the use of silicone gel breast implants for primary breast augmentation in women age 22 and older. Ongoing studies of modern silicone gel implants have found a safety profile similar to that of saline breast implants, which have been in use for over four decades. Your surgeon will be able to share more specific study results and talk with you about the latest findings during your consultation, but the safety of modern silicone gel implants, coupled with their more natural look and feel, has led them to become the primary implant option for women today.
Contact the cosmetic surgery Health Care specialist:www.wellnesskliniek.com